Zhongyuan Union Cell & Gene Engineering Corporation Overview
- Status
-
Public
- Employees
-
2,231
- Stock Symbol
-
600645
- Investments
-
10
- Share Price
-
$2.63
- (As of Friday Closing)
Zhongyuan Union Cell & Gene Engineering Corporation General Information
Description
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Contact Information
Primary Industry
Biotechnology
Stock Exchange
SHG
Primary Office
- Room 406, No. 45 Doungjiu Avenue
- Tianjin Airport Economic Zone
- Tianjin, 300304
- China
+86 022 0000 0000
Zhongyuan Union Cell & Gene Engineering Corporation Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.63 | $2.61 | $2.17 - $4.51 | $1.23B | 468M | 5.45M | $0.02 |
Zhongyuan Union Cell & Gene Engineering Corporation Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 950,200 | 1,699,388 | 1,280,041 | 1,030,325 |
| Revenue | 236,737 | 237,774 | 190,906 | 200,702 |
| EBITDA | 16,128 | 52,622 | 1,725 | 31,026 |
| Net Income | 12,060 | 24,054 | (18,363) | 7,192 |
| Total Assets | 733,502 | 789,661 | 759,469 | 698,682 |
| Total Debt | 16,822 | 11,076 | 16,911 | 19,367 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Zhongyuan Union Cell & Gene Engineering Corporation Executive Team (10)
Zhongyuan Union Cell & Gene Engineering Corporation Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000 | Zhongyuan Union Cell & Gene Engineering Corporation | Independent Director | 000 0000 |
| 000000000 000 | Zhongyuan Union Cell & Gene Engineering Corporation | Independent Director | 000 0000 |
Zhongyuan Union Cell & Gene Engineering Corporation Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Zhongyuan Union Cell & Gene Engineering Corporation Investments & Acquisitions (10)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 03-Aug-2022 | 000000000 | Biotechnology | ||
| 00000000 0000 | 13-Dec-2018 | 00000 0000 | 000.00 | Drug Discovery | |
| 0000000 | 13-Feb-2017 | 0000000000 | Discovery Tools (Healthcare) | ||
| 00000000 0000 | 19-Sep-2016 | 00000 0000 | 000.00 | Diagnostic Equipment | |
| iCarbonX | 12-Apr-2016 | Early Stage VC | Laboratory Services (Healthcare) |
Zhongyuan Union Cell & Gene Engineering Corporation Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Origene | Discovery Tools (Healthcare) | Rockville, MD | 1996 |
| 00000000 00000000 | Other Pharmaceuticals and Biotechnology | Pudong, China | 0000 |
Zhongyuan Union Cell & Gene Engineering Corporation Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 000000 | 19-Sep-2016 | 00000 00000 00 | 000.00 | Completed |
|
| Aeon Therapeutics | 01-Jan-2002 | Joint Venture | Completed |
|